Crossref

1. Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis

- Mehmet Sayiner

- Munkhzul Otgonsuren

- Rebecca Cable

- Issah Younossi

- Mariam Afendy

- Pegah Golabi

- Linda Henry

- Zobair M. Younossi

2. Association between exposures to brominated trihalomethanes, hepatic injury and type II diabetes mellitus

- Konstantinos C. Makris

- Xanthi D. Andrianou

- Pantelis Charisiadis

- James B. Burch

- Ratanesh K. Seth

- Androniki Ioannou

- Michael Picolos

- Costas A. Christophi

- Saurabh Chatterjee

3. Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease

- Mehmet Sayiner

- Maria Stepanova

- Huong Pham

- Bashir Noor

- Mercedes Walters

- Zobair M Younossi

4. How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?

- Alireza Ghaemi

- Fourugh Azam Taleban

- Azita Hekmatdoost

- Alireza Rafiei

- Vahid Hosseini

- Zohreh Amiri

- Reza Homayounfar

- Hafez Fakheri

5. Nonalcoholic fatty liver disease - A multisystem disease?

- Ivana Mikolasevic

- Sandra Milic

- Tamara Turk Wensveen

- Ivana Grgic

- Ivan Jakopcic

- Davor Stimac

- Felix Wensveen

- Lidija Orlic

6. Increasing Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease Among Hospitalized Adults in the United States

- Grishma Hirode

- Eric Vittinghoff

- Robert J. Wong

7. Non-alcoholic fatty liver disease is not associated with a lower health perception

- Liat Mlynarsky

- Dalit Schlesinger

- Roni Lotan

- Muriel Webb

- Zamir Halpern

- Erwin Santo

- Oren Shibolet

- Shira Zelber-Sagi

8. Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study

- Jamie O'Hara

- Alan Finnegan

- Harpal Dhillon

- Leonardo Ruiz-Casas

- Gabriel Pedra

- Bethany Franks

- George Morgan

- Vanessa Hebditch

- Bengt Jönsson

- Mzwandile Mabhala

- Tatjana Reic

- Ingo Van Thiel

- Vlad Ratziu

- Manuel Romero-Gomez

- Elisabetta Bugianesi

- Jörn M. Schattenberg

- Quentin M. Anstee

9. Overall clinical and economic impact of non-alcoholic fatty liver disease

- Antoni Sicras-Mainar

- Rocío Aller

- Javier Crespo Garcia

- José Luis Calleja

- Juan Turnes

- Manuel Romero-Gómez

- Salvador Augustín

10. Alcoholic liver disease: Treatment

- Ki Tae Suk

11. Non-alcohol fatty liver disease in Asia: Prevention and planning

- Sara Ashtari

12. Liver Fibrosis and Cirrhosis in Patients with Non-alcoholic Fatty Liver with and without History of Cholecystectomy: A Pilot Study

- Abazar Parsi

- Eskandar Hajiani

- Somayeh Sadani

- Seid Jalal Hashemi

- Seid Saeed Seyedian

- Mehdi Alimadadi

- Reza Ghanbari

13. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis

- Limin Cao

- Yu An

- Huiyuan Liu

- Jinguo Jiang

- Wenqi Liu

- Yuhan Zhou

- Mengyuan Shi

- Wei Dai

- Yanling Lv

- Yuhong Zhao

- Yanhui Lu

- Liangkai Chen

- Yang Xia

14.

15. Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system

- Thomas Gerard Cotter

- Li Dong

- John Holmen

- Richard Gilroy

- Jake Krong

- Michael Charlton